Equibles does not estimate personal net worth.
Get an email with a short summary when Arcadia Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get RKDA alertsStan Jacot is recorded as CEO at Arcadia Biosciences, Inc. (RKDA) since February 2, 2022. Stan Jacot has spoken on 9 earnings calls across 1 company, most recently for Arcadia Biosciences, Inc. on May 9, 2024. Arcadia Biosciences, Inc. is classified in the Packaged Foods industry within the Consumer Defensive sector. Other leadership on record at Arcadia Biosciences, Inc. includes Kevin Comcowich (CEO), Rajendra Ketkar (CEO), Thomas J. Schaefer (CEO, CFO, Chief Accounting Officer and Board Member) and 7 others.
“Good afternoon, everyone, and thank you for joining us today to review our first quarter results for 2024. Since we last talked 6 weeks ago, I am pleased to report that the positive business trends from Q4 2023 have continued in Q1 2024.”
“Good afternoon everyone, and thank you for joining us today to review our fourth quarter and full year results for 2023.”
“I am pleased to report that Arcadia continues to make excellent progress in executing Project Greenfield, our three-year strategic plan to unlock the company’s potential and provide a path to profitability.”
“Good afternoon, everyone, and thank you for joining us for our 2023 second quarter conference call. I am pleased to report that Arcadia continues to make progress and executing Project Greenfield, our three-year strategic plan to unlock the company's potential and provide a path to profitability.”
“Good afternoon, everyone, and thank you for joining us for our 2023 first quarter conference call.”
2022-02-02–present
Start not stated–2024-07-02
Packaged Foods · Consumer Defensive
CEO
2022-02-02–present
